Asia-Pacific Solutions Brochure

Supporting your drug development journey with strong Asia presence

In addition to Japan, CMIC Group has 135 active clinical trial sites in China, Thailand, Hong Kong, Vietnam, Malaysia, Singapore, Australia, New Zealand, Indonesia, Taiwan, South Korea and the Philippines. We have the capability to support our client’s clinical trials throughout Asia Pacific region.